The goal of this volume is to comprehensively cover a highly readable, updated and extended, overview on our present knowledge of positive and negative effects of UV-exposure, with a focus on vitamin D and skin cancer. Topics that are discussed in-depth by leading researchers and clinicians range from the newest findings in endocrinology, epidemiology, histology, photobiology, immunology, cytogenetics and molecular pathology to new concepts for prophylaxis and treatment. Experts in the field as well as health care professionals not intimately involved in these specialized areas are provided with the most significant and timely information related to these topics. It is the aim of the second edition of this book to summarize essential up-to-date information for every clinician or scientist interested in how to balance between positive and negative effects of UV-exposure to minimize the risks of developing vitamin D deficiency and skin cancer.

The Physics of Three Dimensional Radiation Therapy presents a broad study of the use of three-dimensional techniques in radiation therapy. These techniques are used to specify the target volume precisely and deliver radiation with precision to minimize damage to surrounding healthy tissue. The book discusses multimodality computed tomography, complex treatment planning software, advanced collimation techniques, proton radiotherapy, megavoltage imaging, and stereotactic radiosurgery. A review of the literature, numerous questions, and many illustrations make this book suitable for teaching a course.
The themes covered in this book are developed and expanded in Webb's The Physics of Conformal Radiotherapy and the two may be used together or in successive semesters for teaching purposes.

This volume elucidates state-of-the-art findings of uterine fibroids and adenomyosis, incorporating expert basic knowledge. Uterine fibroids and adenomyosis are common uterine tumors in reproductive-age women. However, the pathogenesis of the tumors is still poorly understood, and both genetic and environmental factors may be involved in their generation or development. Recent research on the genomics and molecular biology of uterine fibroids and adenomyosis has facilitated a better understanding of the pathogenesis and pathophysiology of these benign tumors. Renowned experts provide detailed discussions of basic research and clinical aspects of uterine fibroids and adenomyosis in this book, from histopathology and molecular pathogenesis to diagnosis and the latest treatment of uterine fibroids, including pregnancy complications of adenomyosis. A great deal of information and a deep understanding of molecular and genetic biology have led to development of more innovative treatments of these tumors. Thus this book benefits not only oncologists, seasoned gynecologists, and obstetricians, but also molecular biologists and other basic researchers who are involved in the treatment of uterine fibroids.

Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product. Introducing the definitive gynecologic oncology reference and surgical atlas-in one essential text. A Doody's Core Title for 2017! Gynecologic Oncology: Clinical Practice and Surgical Atlas brings together a skill-sharpening reference and full-color atlas to deliver an unmatched introduction to the field. As the most comprehensive, evidence-based gynecologic oncology resource available, this all-in-one resource offers high-yield coverage of the discipline's underlying principles and proven management strategies. Each topic is written by experts and is presented in an easily accessible, consistent presentation that highlights clinical practice guidelines, along with the diagnosis and treatment of specific malignancies. This authoritative coverage is reinforced by the state-of-the-art surgical atlas, which offers a richly illustrated, overview of essential procedures designed to build your knowledge and confidence. FEATURES Consistent, streamlined presentation for each disease consists of: Epidemiology, Pathology, Clinical Presentation, Diagnosis, Staging, Treatment, Survival, Key management strategies Thorough examination of basic gynecological oncology topics, including epidemiology, clinical trial design, biostatistics, genetics and biology of gynecologic cancers, and diagnostic modalities Instructive, A-to-Z coverage of disease sites-from cervical cancer and gestational trophoblastic disease, to epithelial ovarian cancers and breast cancer-emphasizes evidence-based practice guidelines and critical supporting data In-depth, hands-on look at clinical management topics provides an up-to-date survey of perioperative and critical care; the principles of chemotherapy, radiation therapy, and immunotherapies; and quality of care and quality of life Full-color design filled with more than 600 figures, tables, algorithms, color photos, and illustrations Key points helpfully review the main topics to be covered in specific chapters, while chapter conclusions offer convenient summaries of each chapter's core concepts Chapter-ending references underscore the book's evidence-based approach

"This book is an excellent resource for nurses working in either a hospital or primary care"
--"Breast Cancer Care News"

"This book would be really helpful to other breast cancer nurses and students about to embark on work in this field"
--"Journal of Community Nursing"

This comprehensive handbook is for nurses and other healthcare professionals involved in the care of people with breast cancer. It gives up-to-date evidence-based information and practical advice on nursing care throughout diagnosis, treatment, recovery and end-of-life care.

Each chapter is written by an expert in the field. Topics include the anatomy of the breast, available treatments, complementary therapies, the psychological care of patients and their families, and the role of the specialist nurse. This book provides a well-balanced approach to all aspects of managing breast malignancy. The importance of writing from a nursing perspective is underlined so that the essence of support and bedside care is maintained.

This second edition includes: Updates on guidelines as well as references to recent trials and changes to the breast screening programmeA new chapter on survivorship issues covering the long-term consequences and effects of recovering from breast cancer

This textbook addresses themes ranging from the molecular issues of cancer sciences to clinical practice in medical oncology. It clarifies many topics, including molecular oncology, chemotherapy pharmacology and practical issues for clinicians. Systemic treatments in many areas of oncology feature, such as breast cancer, gastrointestinal, thoracic, urological oncology, head and neck tumors, bone tumors, sarcomas and palliative care. An excellent source for young physicians and researchers in the field of oncology, this book furthers understanding of medical oncology practice and facilitates professionals' treatment of cancer patients. It sets the direction for future research in the field, and will become the readers' regular working tool.

This unique book summarizes current knowledge on co-development of infectious diseases and cancer. It provides an overview of the complex and unique role of the immune system, inflammation, tumor-mediated immunosuppression and infection-induced immunomodulation in cancer and infection progression. Chapters are organized into themed parts, beginning with a look at the historical perspective of human tumor viruses, then aspects and examples of infection-related cancers and cancer-associated infections. The work discusses how cancer- and infection-associated immune responses interact in a bi-directorial fashion and how these interactions may evolve during both disease progression and in response to therapy. The phenomenon of independent development of cancer and infection in the same host, known as comorbid cancer-infection progression, is explored. Understanding the complex pathways involved in the progression of infection and cancer will allow the prevention of the development of certain types of cancer, as well as advancing prophylactic anti-cancer vaccines. Readers of this work will discover innovative approaches for multidisciplinary projects, focusing on the design of original therapeutic modalities for cancer therapy. The book will therefore be particularly valuable to scholars interested in cancer immunology and researchers and clinicians in the field of basic and applied immunobiology and microbiology.

Cryosurgery is a surgical technique that employs freezing to destroy undesirable tissue. From as early as 3500 BC, there is evidence for the use of cold in medicine for the treatment of infected wounds of the chest, fracture of the skull and various injuries. However, the history of "modern" cryosurgery is relatively short and is closely intertwined with the development in low temperature physics, engineering, and instrumentation during the last century. From the early 21st century, advanced helium-based cryosurgery has been applied worldwide. More than ten thousand patients with malignant and benign tumors have received cryosurgery. It is specially noted that in most cases cryosurgery, as a mini-invasive ablation technique, was performed with percutaneous approach under guidance of CT or ultrasound. Cryosurgery is now one of the more popular techniques in China, with nearly 6000 cases of tumors receiving cryosurgery in the author's institution alone. This book summarizes the experimental and clinical experience and practice of cryosurgery, and describes the basics of cryosurgery and its use in the treatment of various tumors.

This atlas contains excellent clinical and histopathologic images and text of each of the types of cutaneous lymphoma (around 25 entities). It is the first go-to text for those who are considering a diagnosis of cutaneous lymphoma in their differential diagnosis. The text also includes diagnostic mimics of lymphoma and differential diagnosis tables and algorithms. The target audience is general practitioners, dermatologists, pathologists and students, residents and fellows. The diagnosis of lymphoma in the skin is confounded by the myriad of disorders that can mimic lymphoma clinically and histopathologically and by inconsistencies in the diagnostic classification that have only recently been resolved. In the last decade the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Group and the World Health Organization (WHO) Collaborated in a series of workshops and consensus meetings to arrive at a definitive classification scheme for cutaneous lymphoma. Unfortunately, the publication by the WHO that described this schema included all lymphomas and has the skin tumors scattered throughout the volume. There is currently no go to text for those who are considering a diagnosis of cutaneous lymphoma in their differential diagnosis. As a result there continues to be confusion about the diagnosis of cutaneous lymphoma, although this classification scheme was published in 2008.

Over the last decades the incidence of skin cancers is dramatically increasing world-wide. This is not only confined to the incidence of melanoma but includes also other skin cancers such as basal cell carcinomas. Based on the recent WHO classification of skin cancers, this lavishly illustrated reference book covers comprehensively the epidemiology, histology and pathology, as well as diagnostic signs and treatment options of skin cancers. Homogenously and reader-friendly structured, it links the diagnostic and genetic features of each disease in order to guide the reader to the most appropriate therapeutic strategies for the best possible treatment outcome. In order to demonstrate the world wide activities in the field, all chapters cover the variations of the individual experiences and expertise in different nations.

This text is the only book of its kind to provide specific guidance applicable to limited resource settings and builds up from the foundation of general practitioner or general pediatrician competence. Written and edited by leaders in the field, this manual educates physicians on the essential components of the discipline, filtered through the experience of specialists from developing countries, with immediate applicability in the specific healthcare environment in these countries. Typically, manuals of pediatric hematology-oncology are written by specialists from high-income countries, and usually target an audience with a sub-specialist level of training, often assisted by cutting-edge diagnostic and treatment facilities. However, approximately 80% of new cases of cancer in children appear in mid- and low-income countries. Almost invariably, general practitioners or general pediatricians without special training in oncology will look after children with malignancies who enter the health care system in these countries. The diagnostic facilities are usually limited, as are the treatment options. The survival figures in these conditions are somewhere below 20%, while in high-income countries they are in the range of 80% for many childhood cancers. This book includes simplified therapy protocols, pain therapy and palliation, as well as ward procedures such as bone marrow aspiration/biopsies, intravenous therapy and chemotherapy drugs mixing. It provides an overview of pediatric cancer epidemiology, cancer registration and organizing support networks and features the management of cancers with associated pathology like AIDS, malnutrition, malaria and tuberculosis.

Over the past decade, PET-CT has achieved great success owing to its ability to simultaneously image structure and function, and show how the two are related. More recently, PET-MRI has also been developed, and it represents an exciting novel option that promises to have applications in oncology as well as neurology. The first part of this book discusses the basics of these dual-modality techniques, including the scanners themselves, radiotracers, scan performance, quantitation, and scan interpretation. As a result, the reader will learn how to perform the techniques to maximum benefit. The second part of the book then presents in detail the PET-CT and PET-MRI findings in cancers of the different body systems. The final two chapters address the use of PET/CT in radiotherapy planning and examine areas of controversy. The authors are world-renowned experts from North America, Europe, and Australia, and the lucid text is complemented by numerous high-quality illustrations.

The book focuses on two concurrent experimental therapies in cancer treatment known as boron neutron capture therapy (BNCT) and gadolinium neutron capture therapy (GdNCT) using a variety of boron- and gadolinium-based compounds. Some of the gadolinium compounds serve the dual purpose as being MRI contrast agents and GdNCT agents. The book describes why BNCT & GdNCT were not at the forefront of the clinical trials during the past seven to eight decades since the discovery of neutrons by John Chadwick in 1932 and how the latest development in the synthesis of target boron- and gadolinium-based drugs have turned the area to be the hottest one and worthy of further investigation with the new clinical trials in the USA and elsewhere.

A twelve-year cancer survivor and oncology rehabilitation specialist, Dr. Julie K. Silver wrote After Cancer Treatment to help others recover from the exhaustion and physical devastation that often follow treatment. This new edition of the book, retitled Before and After Cancer Treatment, describes improved therapies, better delivery of care, holistic care options, and energetics. In covering the benefits of prehabilitation strategies, which improve physical and emotional strength before beginning therapy, the book adds another dimension to the experience of cancer treatment. Dr. Silver fills this survivor-oriented book with exercise and diet recommendations as well as step-by-step instructions for fighting fatigue, monitoring mood, and overcoming setbacks. Readers are encouraged to set balanced goals, take time to heal, and consult both conventional and alternative medicine. Most people will live for many years after their initial cancer diagnosis-often cured or in remission. Some will live with cancer as a chronic condition. The goal is always to live life to the fullest, which means feeling as strong as possible-physically and emotionally. Dr. Silver recommends daring to dream again and preparing for the future. Wherever they are in their own journey with cancer, readers will find here a personal, practical, and powerful guide to recovery.

Toxicogenomics in Predictive Carcinogenicity describes toxicogenomics methods in predictive carcinogenicity testing, mode of action and safety evaluation, and cancer risk assessment. It illustrates these methods using case studies that have yielded significant new information on compounds and classes of compounds that have proven difficult to evaluate using conventional methods alone. This book additionally covers current and potential toxicogenomic research using stem cells as well as new bioinformatics methods for drug discovery and environmental toxicology.The information is needed because it has not previously been available. With the increasing complexity of research in mode of action investigations it is important to gain a better understand of approaches to data integration and health risk assessment. Furthermore, it is essential to consider how novel test systems and newer methods and approaches may be used in future to gain a better understanding of mechanisms. The proposed publication will provide details of chemical case studies not available in previous volumes and will demonstrate how various data is assembled and integrated to arrive at an informed assessment of chemical safety and human health risk. It will be the most current volume which comprehensively covers the subject. This publication is an indispensable tool for postgraduates, academics and industrialists working in biochemistry, genomics, carcinogenesis, pathology, pharmaceuticals, food technology, bioinformatics, risk assessment and environmental toxicology. Societies: American Association for Cancer Research AACR (http://www.aacr.org/) Environmental Mutagenesis and Genomics Society (http://www.emgs/org) International Association of Environmental Mutagen Societies (http://www.iaems/org) International Union of Toxicology (http://www.iutox.org/) Society of Toxicology (http://www.toxicology.org/) Journals for reviews: Cancer Research Mutation Research Toxicology Research Toxicology and Applied Pharmacology Regulatory Toxicology and Pharmacology Toxicology Toxicology Letters Critical Reviews in Toxicology Archives of Toxicology Pharmacology & Toxicology Fundamental and Applied Toxicology Toxicologic Pathology Clinical Toxicology Human and Experimental Toxicology International Journal of Toxicology Toxicology and Industrial Health Drug and Chemical Toxicology Drug safety Journal of Toxicology Toxicological Sciences Websites: American Association for Cancer Research AACR (http://www.aacr.org/) Environmental Mutagenesis and Genomics Society (http://www.emgs/org) International Association of Environmental Mutagen Societies (http://www.iaems/org) International Union of Toxicology (http://www.iutox.org/) Society of Toxicology (http://www.toxicology.org/) Cross-promote with the textbook Fundamental Toxicology

Cancer research is at a crossroads. Traditionally, cancer has been thought of as a disease of gene mutation, where the stepwise accumulation of cancer gene mutations is the key, and the identification of common gene mutations has been considered to be essential for diagnosis and treatment. Despite extensive research efforts and accumulated knowledge on cancer genes and pathways, the clinical benefits of this traditional approach have been limited. Recently, cancer genome sequencing has revealed an extensive amount of genetic heterogeneity where the long-expected common mutation drivers have been difficult, if not impossible, to identify. These realities ultimately challenge the conceptual framework of current cancer biology.This book introduces a new concept of genome theory of cancer evolution, in an attempt to unify the field. Many important and representative, but often confusing, questions and paradoxes are critically analyzed. By comparing gene- and genome-based theories, the hidden flaws of many popular viewpoints are addressed. This discussion is intended to initiate a much-needed critical re-evaluation of current cancer research.

Provides the information necessary to guide clinicians to more efficient and appropriate use of the cardiac imaging modalities at their disposal Most books currently available on cardiac imaging focus on just modality. As the number of imaging options has increased, the choice of procedure has become more complicated. This comprehensive book will guide the practitioner in choosing the most appropriate test when confronted by various cardiac symptoms and diseases and to understand the benefits and limitations of each imaging modality. It demonstrates the advantages and disadvantages of various imaging modalities such as echocardiography, computer tomography, MRI, and nuclear cardiology in the evaluation of various disease states both commonly and infrequently seen in a standard practice. Comparative Cardiac Imaging--A Case-based Guide utilizes actual case examples to demonstrate the state of the art in comparative cardiac imaging. It offers in-depth chapter coverage of Aortic Diseases; Aortic Valvular Diseases; Mitral Valvular Diseases; Prosthetic Valves; Coronary Artery Disease; Pulmonary Artery Diseases; Congenital Heart Disease; Cardiac Tumor; Infective Disease; Cardiomypathy; and Cardiac Trauma. Uniquely focuses on and compares the many different modalities for cardiac imaging Breaks the topic down by anatomy and pathophysiology in order to cover all aspects of non-invasive cardiac imaging Covers newer and lesser known modalities like speckle tracking and velocity vector imaging Offers coverage of more controversial topics, such as CT angiography Comparative Cardiac Imaging--A Case-based Guide presents a level of data that is appropriate for the practicing cardiologist and cardiology trainee, as well as residents, internists, and other primary care clinicians.

Significant progress in engineering has allowed the production of devices that can optically detect, differentiate and treat surface or near-surface cancers. The ability to differentiate cancerous from non-cancerous tissue in vitro using light represents a potentially significant advance in patient care, eliminating needless repeat procedures. With the help of advanced optical technologies, clinicians are able to identify cancers earlier, determine surgical margins at the time of surgery, and monitor treatment results without using expensive and insensitive imaging.

This volume describes the state-of-the-art optical detection technologies in varying stages of cancer development. Written by an international panel of basic researchers, engineers and clinicians, the book is designed to give an up-to-date overview of the most recent advances for researchers and medical professionals who are interested in the biophotonic detection of cancer.

This is the story of a son's journey to achieve justice and closure following the death of his father from industrial disease and corporate negligence. As a working class man from Romford, Graham describes his unconventional path to becoming a doctor after a turbulent childhood of maternal illness, a spell in a children's home, fostering with relatives and the final badge of under achievement, 11 plus failure. During his medical training, Graham's father died after developing disseminated cancer. There were strong grounds for suspecting occupational exposure to asbestos as the cause but, to the family's dismay, this diagnosis failed to be recognised at post-mortem. Two of Graham's uncles who had worked alongside his father as boiler coverers before the war suffered a similar fate but were correctly diagnosed with asbestos-induced tumours and their families received appropriate compensation. After a decade spent becoming a cancer and leukaemia specialist, and with the help of a pathologist colleague, the cause of Graham's father's death was re-visited and the correct diagnosis of mesothelioma secondary to asbestos was finally confirmed. A case was eventually brought to the High Court against his former employer, the multinational conglomerate, Turner and Newall, and the claim was successful with the award of substantial damages. This story highlights the corporate deceit and indifference shown by the industry towards the health of their workers and how the press exposure of Graham's family's tragedy helped contribute towards the eventual demise of the company. The lessons regarding the wider social responsibility of corporations and the importance of industrial health and safety regulations are still being learnt today.

Ever wondered if your patient's new symptoms are a manifestation of metastatic disease, treatment effects or are altogether unrelated to the cancer diagnosis; whether herbal remedies interact with cancer treatment; when to refer for genetic testing; or how to provide informed advice regarding dietary and lifestyle modifications? This volume answers these and many other questions, spanning from cancer prevention to palliative care. Each chapter is comprehensively referenced, to allow the reader to explore related fields in more detail. The book is unique in summarizing a large amount of information that is beyond conventional oncology textbooks. While cancer is treated by multidisciplinary teams of medical oncologists, hematologists, surgeons and radiation oncologists, other specialists are called upon to treat symptoms, side effects or other diseases that can occur concurrently with cancer. In addition to the physical challenges brought about by a cancer diagnosis, patients and their relatives need sensitive and skilled psychosocial support throughout the cancer journey. The book brings together specialists from a wide range of medical, surgical, psychological and supportive specialties, while keeping the focus on the interdisciplinary management of cancer.

Important scientific discoveries and ever-changing guidelines for how to identify and manage patients with hereditary cancer syndromes are constantly evolving. This Third Edition of Counseling About Cancer is completely updated and expanded to feature five entirely new chapters on breast cancer, colon cancer, other solid tumors, clients and families, and genetic test results and follow-up. This is the only reference and clinical book on the market for cancer genetics counselors and other healthcare providers who must quickly assimilate complex and ever-changing data on the hereditary risk for cancer.

This book presents, in condensed form, the clinical results achieved by means of various locoregional tumor therapies employed for different indications. In so doing, it will allow the reader to rapidly retrieve the information on indications and effectiveness that is required for optimal integration of these highly effective therapies into modern, complex treatment strategies. The renaissance in locoregional tumor therapies is an ongoing process. New chemotherapeutic schedules, especially for liver and lung tumors, have been developed during the past few years. Other targeted therapies, such as radioembolization, microwave ablation, and HIFU techniques, and new pharmaceuticals for intra-arterial therapy have been developed and implemented in clinical practice. Furthermore, the advantages of unlimited combination of starch microspheres with various antitumor agents, supported by effective ischemia, have been increasingly exploited. The second edition of this book reflects these advances and includes entirely new chapters on the role of intraperitoneal perfusion in treating peritoneal carcinomatosis and the use of limb perfusion. Locoregional Tumor Therapy will be invaluable for all practitioners who work with cancer patients.

This new atlas, the fourth of a successful series, is a completely revised and updated edition of a previously published FDG PET-CT atlas. In the past few years, considerable progress has been made in the field of PET-CT imaging, and this new edition takes full account of these recent developments. Furthermore, its educational mission has been broadened: beyond serving as a straightforward guide to FDG PET-CT imaging it now encompasses the integrative use of contrast-enhanced CT and MRI. The new edition also includes non-oncological indications for FDG PET-CT. The atlas aims to help imaging practitioners to recognize physiological and benign pathological FDG uptake and illustrates in a case-based, practical manner the PET-CT appearances of all the major tumors and infectious, inflammatory, and neurodegenerative disorders. The main clinical applications are covered, and learning points and pitfalls are clearly articulated. The consistent, user-friendly format facilitates image interpretation and allows rapid review of key information needed for FDG PET-CT imaging.

The 1st edition of Error Reduction and Prevention in Surgical Pathology was an opportunity to pull together into one place all the ideas related to errors in surgical pathology and to organize a discipline in error reduction. This 2nd edition is an opportunity to refine this information, to reorganize the book to improve its usability and practicality, and to include topics that were not previously addressed. This book serves as a guide to pathologists to successfully avoid errors and deliver the best diagnosis possible with all relevant information needed to manage patients. The introductory section includes general principles and ideas that are necessary to understand the context of error reduction. In addition to general principles of error reduction and legal and regulatory responsibilities, a chapter on regulatory affairs and payment systems which increasingly may be impacted by error reduction and improvement activities was added. This later chapter is particularly important in view of the implementation of various value-based payment programs, such as the Medicare Merit-Based Incentive Payment System that became law in 2015. The remainder of the book is organized in a similar manor to the 1st edition with chapters devoted to all aspects of the test cycle, including pre-analytic, analytic and post-analytic. The 2nd Edition of Error Reduction and Prevention in Surgical Pathology serves as an essential guide to a successfully managed laboratory and contains all relevant information needed to manage specimens and deliver the best diagnosis.